BriaCell Therapeutics Corp (BCT) Stock Price, News, Quotes-Moomoo

CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist

1.100
-0.060-5.17%

15min DelayMarket Closed Nov 1 16:00 ET

39.80MMarket Cap-2750P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

10-K: FY2024 Annual Report
SECOct 29 13:23 ET · Announcements
Express News | Briacell Therapeutics Corp - No Briacell-Imt Related Discontinuations Reported
ReutersOct 22 07:50 ET
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
GlobeNewswireOct 22 07:50 ET
Express News | Briacell Therapeutics Corp - Multiple Briacell Patients Show Over 2 Years Survival
ReutersOct 22 07:50 ET
BriaCell Gains After Update on Late-stage Trial for Lead Asset
Seeking AlphaOct 15 10:52 ET
Express News | Briacell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
ReutersOct 15 07:50 ET

Comments

Stock Region

Jul 19 19:22

Therapeutics Company Reports Major Progression In Its Phase 2 Study Battling Cancer

BriaCell Quadruples Progression-Free Survival in Metastatic Breast Cancer Patient.
The field of oncology has witnessed numerous advancements over the years, yet metastatic breast cancer continues to pose challenges. However, recent developments reported by BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) offer a glimmer of hope. The clinical-stage biotechnology company, known for its innovative immunot...

Heat List

Overall

No Data